Clinical study on the precise diagnosis and treatment of nonalcoholic fatty liver disease with Trinity therapy combined with fibrotouth Technology
- Conditions
- nonalcoholic fatty liver disease
- Registration Number
- ITMCTR2000004000
- Lead Sponsor
- Shanghai Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1) Patients with nonalcoholic fatty liver disease who meet the above diagnostic criteria of Western medicine.
2) Aged between 18-55 years old, can adhere to the treatment, no allergy to traditional Chinese medicine.
3) Patients with good compliance and complete clinical data required for follow-up.
1) The patients with drinking history or alcohol equivalent alcohol volume less than 40g per week;
2) Those aged less than 18 years or more than 65 years;
3) Women who are lactating or pregnant or planning to be pregnant;
4) Those who need long-term medication for hypertension, diabetes, heart disease and blood system diseases;
5) Serum transaminase (alt, AST) increased at 80u /L;
6) Patients with viral hepatitis, drug-induced liver disease, Wilson's disease, total parenteral nutrition and autoimmune liver disease;
7) Patients who have received other related drug treatment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical symptoms and signs;Detection of transient elastography;B ultrasound of abdomen;body mass index;Liver and kidney function;blood viscosity;blood fat;
- Secondary Outcome Measures
Name Time Method the waist;weight;